5-CHLORO-2-(2-(2-(DIETHYLAMINO)ETHOXY) ETHYL)-2-METHYL-1,3-BENZODIOXOLE

Suppliers

Names

[ CAS No. ]:
56287-41-3

[ Name ]:
5-CHLORO-2-(2-(2-(DIETHYLAMINO)ETHOXY) ETHYL)-2-METHYL-1,3-BENZODIOXOLE

[Synonym ]:
lr-529

Chemical & Physical Properties

[ Density]:
1.115g/cm3

[ Boiling Point ]:
381ºC at 760 mmHg

[ Molecular Formula ]:
C16H24ClNO3

[ Molecular Weight ]:
313.82000

[ Flash Point ]:
184.2ºC

[ Exact Mass ]:
313.14400

[ PSA ]:
30.93000

[ LogP ]:
3.57590

[ Index of Refraction ]:
1.512

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DF4912790
CHEMICAL NAME :
1,3-Benzodioxole, 5-chloro-2-(2-(2-(diethylamino)ethoxy)ethyl)-2 -methyl-
CAS REGISTRY NUMBER :
56287-41-3
LAST UPDATED :
199109
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C16-H24-Cl-N-O3
MOLECULAR WEIGHT :
313.86
WISWESSER LINE NOTATION :
T56 BO DO CHJ C2O2N2&2 C1 GG

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
18 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 226,286,1977
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
111 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 226,286,1977
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 226,286,1977

Related Compounds

  • 1-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methoxybutanoyl]-2-methylpiperidine-2-carboxylic acid
  • (2R)-2-{2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-4-methylpentanamido}-4-(methylsulfanyl)butanoic acid
  • 2-(1-{[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylpentanamido]methyl}cyclobutyl)acetic acid
  • 3-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pyridine-2-amido]oxolane-3-carboxylic acid
  • 1-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoyl]pyrrolidine-3-carboxylic acid
  • 4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-[(1-methoxypropan-2-yl)carbamoyl]butanoic acid
  • (2R)-2-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohexyl]formamido}propanoic acid
  • 2-{2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanamido]ethoxy}acetic acid
  • (2R)-2-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1,3-thiazol-4-yl]formamido}butanoic acid
  • 2-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-N-methylbutanamido]butanoic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.